Update on the nephrotoxicity of novel anticancer agentsâ©.
Clin Nephrol
; 89(3): 149-165, 2018 Mar.
Article
en En
| MEDLINE
| ID: mdl-29350175
ABSTRACT
Anticancer drug-induced kidney disease is a problem commonly encountered by nephrologists. The number of medications employed by oncologists causing acute and chronic kidney injury as well as electrolyte and acid-base disturbances has increased significantly over the past several decades. While conventional chemotherapeutic drugs induce a number of kidney lesions, emergence of very effective and well-tolerated targeted therapies and novel immunotherapies has increased the occurrence of drug-induced acute and chronic kidney injury in cancer patients. This article will review the various kidney lesions observed with these new classes of anticancer drugs.â©.
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Insuficiencia Renal Crónica
/
Lesión Renal Aguda
/
Antineoplásicos
Límite:
Humans
Idioma:
En
Revista:
Clin Nephrol
Año:
2018
Tipo del documento:
Article